 |
ImmunoLogik
Last updated: April 17, 2024
Christian Setz, CEO
Country: Germany | Funding: €301.4K (+)
Website: https://immunologik.de/
ImmunoLogik has identified an active agent that helps patients who have developed a resistance against standard HIV treatment therapies.
Website: https://immunologik.de/
ImmunoLogik has identified an active agent that helps patients who have developed a resistance against standard HIV treatment therapies.
